Phospholipids as cinchocain action site during inhibition of lipoperoxidative reactions in rat liver microsomes.
D000818:Animals; D001205:Ascorbic Acid / Q000378:metabolism; D001665:Binding Sites / Q000187:drug effects; D001711:Biotransformation; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D003579:Cytochrome Reductases / Q000378:metabolism; D003992:Dibucaine / Q000494:pharmacology*; D004579:Electron Transport / Q000187:drug effects; D066298:In Vitro Techniques; D050356:Lipid Metabolism; D008297:Male; D008797:Metyrapone / Q000494:pharmacology; D008862:Microsomes, Liver / Q000378:metabolism*; D009249:NADP / Q000378:metabolism; D010084:Oxidation-Reduction; D010101:Oxygen Consumption / Q000187:drug effects; D010544:Peroxidases / Q000378:metabolism; D010545:Peroxides / Q000378:metabolism; D010714:Phosphatidylethanolamines / Q000378:metabolism; D010743:Phospholipids / Q000037:antagonists & inhibitors*; D051381:Rats
D010545:Peroxides; D010714:Phosphatidylethanolamines; D010743:Phospholipids; D009249:NADP; D003577:Cytochrome P-450 Enzyme System; D010544:Peroxidases; D003579:Cytochrome Reductases; D003992:Dibucaine; D001205:Ascorbic Acid; D008797:Metyrapone